Development of 3D Multi-Parametric Ultrasound (MPUS) as a Decision Support Tool for Patients
Part of paid clinical trials in Palo Alto, California.
- Sponsor
- University of California, San Diego
- Study ID
- NCT05705219
- Status
- Recruiting
Conditions
- Liver Cancer, Adult
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- 3D-MPUS — DIAGNOSTIC_TESTParticipants will receive approximately \< 20 minutes ultrasound scan to locate the lesion followed by acquisition of 3D-MPUS acquisition.
Study Details
This clinical trial studies how well 3-dimensional multi-parametric ultrasound (3D MPUS) imaging works as a decision-support tool for patients with liver tumors undergoing therapy. Continuous and dynamic imaging of patients undergoing therapy is required to monitor early-phase treatment response.
Key Dates
- Start date
- Dec 4, 2023
- Status verified
- Jan 2026
- Primary completion
- Dec 31, 2027
- Completion
- Dec 31, 2028
Study Design
- Enrollment
- 80 participants (estimated)
Arms
- Arm: 3-dimensional multi-parametric ultrasound imaging (3D-MPUS)Participants will receive sulfur hexafluoride IV and undergo 3D-MPUS imaging over 20 minutes.
Primary Outcome Measure
Diagnostic yield of the 3D-MPUS data acquisition [ Time Frame: Baseline visit ]
Central Contacts
- David Marcellus, BS(650) 723-4547
- Suzanna Lee+1 (858)-534-1475
Locations (3)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Stanford University, School of Medicine | Palo Alto | California | 94305 | Aya Kamaya, MD (PRINCIPAL_INVESTIGATOR) |
| University of California, San Diego | San Diego | California | 92037 | Allison Law Ahmed El Kaffas, PhD (PRINCIPAL_INVESTIGATOR) |
| Thomas Jefferson Hospital | Philadelphia | Pennsylvania | 19107 | Andrej Lyshchik, MD, PhD (PRINCIPAL_INVESTIGATOR) John Eisenbrey, PhD (SUB_INVESTIGATOR) |
Find similar trials in Palo Alto, CA
Related Studies
- GPC3-Targeted T-Cell Therapy (ECT204) in Adults With Advanced HCCPHASE1/PHASE2 · Recruiting · Eureka Therapeutics Inc. · Duarte, California
- To Test Whether Time-restricted Eating Coupled With a Healthy Diet is Beneficial in Liver Cancer PatientsRecruiting · University of California, San Diego · La Jolla, California